谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Re‐estimation of Drug‐specific Amyloid Removal Parameters and the Rate Constant for Pathogenic Tau Turnover Brings the Q‐ATN Model into Better Alignment with Recent Phase 3 Data from Gantenerumab and Lecanemab

Norman A Mazer,Dominik Lott,Hans Peter Grimm,Matthias Machacek,Frank Boess,Ronald Gieschke,Gregory Klein,Monika Baudler,Rachelle S. Doody

Alzheimer's &amp Dementia（2023）

引用 0|浏览5
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要